When there is a lack of a CSF3R mutation, persistent neutrophilia for at least 3 months, splenomegaly, and absence of identifiable cause of reactive neutrophilia, including an absence of a plasma cell neoplasm or, if identified, demonstration of myeloid cell clonality by molecular or cytogenetic analysis. This evidence concerns the gene CSF3R and plasma cell neoplasm.